SCHEMBL3502139

SCHEMBL3502139

C=CCC(=O)Oc1ccccc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.57
HSD17B10 Q99714 7/20 0.57
HPGD P15428 5/20 0.57
MAPT P10636 1/20 0.57
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
RECQL P46063 1/20 0.56
ALDH1A1 P00352 8/20 0.54
ESR1 P03372 1/20 0.54
ITGB3 P05106 1/20 0.54
ITGA2B P08514 1/20 0.54
HMGB1 P09429 1/20 0.54
TSHR P16473 1/20 0.54
GGT1 P19440 1/20 0.54
PTGS1 P23219 1/20 0.54
PTGS2 P35354 1/20 0.54
BLM P54132 1/20 0.54
NAPRT Q6XQN6 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8850933 0.97 KDM4E (0.54) KDM4EHSD17B10HPGDMAPTKMT2A
SCHEMBL17926777 0.85 KDM4E (0.59) KDM4EHSD17B10HPGDMAPTKMT2A
Diaspirin SCHEMBL30735506 0.80 KDM4E (0.75) KDM4EHSD17B10HPGDMAPTKMT2A
Diaspirin SCHEMBL40799 0.80 KDM4E (0.75) KDM4EHSD17B10HPGDMAPTKMT2A
SCHEMBL844727 0.80 KDM4E (0.70) KDM4EHSD17B10HPGDMAPTKMT2A
SCHEMBL31265186 0.79 KDM4E (0.63) KDM4EHSD17B10HPGDMAPTKMT2A
SCHEMBL31265184 0.79 KDM4E (0.63) KDM4EHSD17B10HPGDMAPTKMT2A
SCHEMBL16800472 0.79 KDM4E (0.63) KDM4EHSD17B10HPGDMAPTKMT2A
SCHEMBL8436639 0.79 KDM4E (0.63) KDM4EHSD17B10HPGDMAPTKMT2A
SCHEMBL14010487 0.78 ALDH1A1 (0.52) KDM4EHSD17B10HPGDMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8227418-B2 Alpha-defensins as anthrax immunotherapeutics MAX-PLANCK-GESELLSCHAFT ZUR FODERUNG DER WISSENSCHAFTEN E.V. (DE) 2012-07-24 US claimed
US-20100143416-A1 Alpha-defensins as anthrax immunotherapeutis MAX-PLANCK GESELLSCHAFT ZUR FODERUNG DER WISSENSCHAFTEN E.V. 2010-06-10 US claimed
EP-1786453-B1 ALPHA-DEFENSINS AS ANTHRAX IMMUNOTHERAPEUTICS MAX PLANCK GESELLSCHAFT (DE) 2009-01-14 EP claimed
EP-1786453-A1 ALPHA-DEFENSINS AS ANTHRAX IMMUNOTHERAPEUTICS Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2007-05-23 EP claimed
WO-2006008162-A1 ALPHA-DEFENSINS AS ANTHRAX IMMUNOTHERAPEUTICS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2006-01-26 WO claimed
JP-8113553-A None JP disclosed
JP-8291138-A None JP disclosed
JP-8209195-A None JP disclosed
US-8227418-B2 Alpha-defensins as anthrax immunotherapeutics MAX-PLANCK-GESELLSCHAFT ZUR FODERUNG DER WISSENSCHAFTEN E.V. (DE) 2012-07-24 US disclosed
US-20100143416-A1 Alpha-defensins as anthrax immunotherapeutis MAX-PLANCK GESELLSCHAFT ZUR FODERUNG DER WISSENSCHAFTEN E.V. 2010-06-10 US disclosed
EP-1786453-B1 ALPHA-DEFENSINS AS ANTHRAX IMMUNOTHERAPEUTICS MAX PLANCK GESELLSCHAFT (DE) 2009-01-14 EP disclosed
EP-1539132-A4 USE OF 2,3 ALKYLCARBONYLOXYBENZOIC ACIDS, DERIVATIVES AND ANALOGUES THEREFROM IN THE TREATMENT OF TISSUE AND CELLULAR DYSFUNCTION DAMAGE AND INJURY IN MAMMALS ADVANCED LIFE SCIENCES INC (US) 2007-10-31 EP disclosed
EP-0572227-B1 Use of an emulsion of a polymer comprising (meth)acrylate units as a dental adhesive MITSUI CHEMICALS INC (JP) 2000-08-23 EP disclosed
US-5629361-A ANTIHYPERSENSITIVE FILMS MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1997-05-13 US disclosed
JP-H08291138-A ANTIFERROELECTRIC LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME SHOWA SHELL SEKIYU KK 1996-11-05 JP disclosed
US-5554669-A DENTAL ADHESIVES MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1996-09-10 US disclosed
JP-H08209195-A PRODUCTION OF GRANULATED BLEACHING ACTIVATOR LION CORP 1996-08-13 JP disclosed
JP-H08113553-A STRONG ANTIFERROELECTRIC LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME SHOWA SHELL SEKIYU KK 1996-05-07 JP disclosed
US-5504111-A Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome MEDICHEM RESEARCH, INC. (US) 1996-04-02 US disclosed
EP-0572227-A1 Polymer having (meth)acrylate unit, emulsion thereof, processes for their productions, and adhesive compositions containing the emulsion MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1993-12-01 EP disclosed